Inventor profile of:

ROBERT RADINSKY

City:

THOUSAND OAKS, California

Country:

United States

Published Applications:

15

Last publication date:

2019-02-14

Top Assignees for applications by ROBERT RADINSKY

The entities that hold a legal rights for patent applications filed by inventor RADINSKY ROBERT:

Recent patent applications by RADINSKY ROBERT

ROBERT RADINSKY from THOUSAND OAKS, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-02-14
US20190048423A1
Chemistry; metallurgy

K-ras mutations and anti-EGFr antibody therapy

#2 | 2018-05-17
US20180134805A1
Chemistry; metallurgy

Material and methods for treating or preventing HER-3 associated diseases

#3 | 2016-08-04
US20160222126A1
Chemistry; metallurgy

Material and methods for treating or preventing HER-3 associated diseases

#4 | 2015-02-19
US20150051091A1
Physics

Methods of selecting epidermal growth factor receptor (EGFr) binding agents

#5 | 2014-01-16
US20140017166A1
Chemistry; metallurgy

Material and methods for treating or preventing HER-3 associated diseases

#6 | 2012-12-27
US20120328620A1
Chemistry; metallurgy

Epidermal growth factor receptor mutations

#7 | 2012-10-18
US20120264129A1
Chemistry; metallurgy

K-ras mutations and anti-EGFr antibody therapy

#8 | 2012-06-21
US20120156130A1
Chemistry; metallurgy

USE OF HER3 BINDING AGENTS IN PROSTATE TREATMENT

#9 | 2012-03-08
US20120058122A1
Chemistry; metallurgy

Antibodies directed to HER-3 and uses thereof

#10 | 2011-09-22
US20110229406A1
Chemistry; metallurgy

Material and methods for treating or preventing HER-3 associated diseases

#11 | 2010-07-22
US20100183631A1
Chemistry; metallurgy

Antibodies directed to HER-3 and uses thereof

#12 | 2009-05-14
US20090123937A1
Physics

Methods of selecting epidermal growth factor receptor (EGFR) binding agents

#13 | 2008-11-27
US20080293055A1
Chemistry; metallurgy

K-ras mutations and anti-EGFr antibody therapy

#14 | 2008-05-29
US20080124345A1
Chemistry; metallurgy

Antibodies directed to HER-3 and uses thereof

#15 | 2007-03-01
US20070048754A1
Chemistry; metallurgy

Epidermal growth factor receptor mutations

InventorID:

613516 ⎘